GSK
$35.93
Revenue | $8117Mn |
Net Profits | $414Mn |
Net Profit Margins | 5.1% |
Gsk Plc-spon Adr.’s revenue jumped 0.81% since last year same period to $8117Mn in the Q4 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 1.31% jump in its revenue since last 3-months.
Gsk Plc-spon Adr.’s net profit jumped 18.29% since last year same period to $414Mn in the Q4 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 813.79% jump in its net profits since last 3-months.
Gsk Plc-spon Adr.’s net profit margin jumped 17.34% since last year same period to 5.1% in the Q4 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 804.56% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.49 |
EPS Estimate Current Year | 0.49 |
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 0.49 - a -60.36% fall from last quarter’s estimates.
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 0.49.
Earning Per Share (EPS) | 0.58 |
Dividend Per Share (DPS) | 0.39 |
Gsk Plc-spon Adr.’s earning per share (EPS) fell -19.56% since last year same period to 0.58 in the Q4 2024. This indicates that the Gsk Plc-spon Adr. has generated -19.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Gsk Plc-spon Adr. declared 0.39 dividend per share during the earnings announcement for Q4 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | 1.23 | 1.29 | 4.88% |
2025-03-03 | 0.49 | 0.58 | 18.79% |
2024-03-31 | 0.91 | 1.09 | 19.78% |
2024-06-30 | 0.99 | 1.1 | 11.11% |